{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:32Z","timestamp":1791938912858,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daegu Metropolitan City"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-026-12687-1","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:16:33Z","timestamp":1781745393000},"page":"8097-8109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of adjunctive quantitative analysis on visual interpretation of amyloid PET: a multiple tracer, multicentre study"],"prefix":"10.1007","volume":"36","author":[{"given":"Seunggyun","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byungwook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junik","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Sim","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-6982","authenticated-orcid":false,"given":"Chae Moon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"12687_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20:5143\u20135169","journal-title":"Alzheimers Dement"},{"key":"12687_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-025-00819-y","volume":"20","author":"DR Thal","year":"2025","unstructured":"Thal DR, Poesen K, Vandenberghe R, De Meyer S (2025) Alzheimer\u2019s disease neuropathology and its estimation with fluid and imaging biomarkers. Mol Neurodegener 20:33","journal-title":"Mol Neurodegener"},{"key":"12687_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s13139-024-00861-6","volume":"58","author":"SK Kang","year":"2024","unstructured":"Kang SK, Heo M, Chung JY et al (2024) Clinical performance evaluation of an artificial intelligence-powered amyloid brain PET quantification method. Nucl Med Mol Imaging 58:246\u2013254","journal-title":"Nucl Med Mol Imaging"},{"key":"12687_CR4","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F et al (2022) Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging 49:3508\u20133528","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2967\/jnumed.123.265766","volume":"65","author":"WJ Jagust","year":"2024","unstructured":"Jagust WJ, Mattay VS, Krainak DM et al (2024) Quantitative brain amyloid PET. J Nucl Med 65:670\u2013678","journal-title":"J Nucl Med"},{"key":"12687_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/diagnostics12030623","volume":"12","author":"J Lee","year":"2022","unstructured":"Lee J, Ha S, Kim REY, Lee M, Kim D, Lim HK (2022) Development of amyloid PET analysis pipeline using deep learning-based brain MRI segmentation\u2014a comparative validation study. Diagnostics 12:623","journal-title":"Diagnostics"},{"key":"12687_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/tomography11080086","volume":"11","author":"Y-k Kang","year":"2025","unstructured":"Kang Y-k, Min JW, Kwon SJ, Ha S (2025) Reliability of automated amyloid PET quantification: real-world validation of commercial tools against Centiloid Project method. Tomography 11:86","journal-title":"Tomography"},{"key":"12687_CR8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/brainsci10120974","volume":"10","author":"M Lee","year":"2020","unstructured":"Lee M, Kim J, Ey Kim R et al (2020) Split-attention U-Net: a fully convolutional network for robust multi-label segmentation from brain MRI. Brain Sci 10:974","journal-title":"Brain Sci"},{"key":"12687_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968\u2013980","journal-title":"Neuroimage"},{"key":"12687_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3233\/JAD-200079","volume":"76","author":"SH Cho","year":"2020","unstructured":"Cho SH, Choe YS, Kim YJ et al (2020) Head-to-head comparison of 18F-florbetaben and 18F-flutemetamol in the cortical and striatal regions. J Alzheimers Dis 76:281\u2013290","journal-title":"J Alzheimers Dis"},{"key":"12687_CR11","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","volume":"41","author":"SM Landau","year":"2014","unstructured":"Landau SM, Thomas BA, Thurfjell L et al (2014) Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers. Eur J Nucl Med Mol Imaging 41:1398\u20131407","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-018-0456-7","volume":"8","author":"MR Battle","year":"2018","unstructured":"Battle MR, Pillay LC, Lowe VJ et al (2018) Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods. EJNMMI Res 8:107","journal-title":"EJNMMI Res"},{"key":"12687_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC et al (2015) The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 11:1\u201315.e11-14","journal-title":"Alzheimers Dement"},{"key":"12687_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","volume":"14","author":"M Navitsky","year":"2018","unstructured":"Navitsky M, Joshi AD, Kennedy I et al (2018) Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale. Alzheimers Dement 14:1565\u20131571","journal-title":"Alzheimers Dement"},{"key":"12687_CR15","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","volume":"44","author":"CC Rowe","year":"2017","unstructured":"Rowe CC, Dor\u00e9 V, Jones G et al (2017) 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids. Eur J Nucl Med Mol Imaging 44:2053\u20132059","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2967\/jnumed.115.171595","volume":"57","author":"CC Rowe","year":"2016","unstructured":"Rowe CC, Jones G, Dor\u00e9 V et al (2016) Standardized expression of 18F-NAV4694 and 11C-PiB \u03b2-amyloid PET results with the Centiloid scale. J Nucl Med 57:1233\u20131237","journal-title":"J Nucl Med"},{"key":"12687_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2967\/jnumed.120.245209","volume":"62","author":"J Therriault","year":"2021","unstructured":"Therriault J, Benedet AL, Pascoal TA et al (2021) Determining amyloid-\u03b2 positivity using 18F-AZD4694 PET imaging. J Nucl Med 62:247\u2013252","journal-title":"J Nucl Med"},{"key":"12687_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.32614\/RJ-2016-021","volume":"8","author":"L Scrucca","year":"2016","unstructured":"Scrucca L, Fop M, Murphy TB, Raftery AE (2016) mclust 5: clustering, classification and density estimation using Gaussian finite mixture models. R J 8:289\u2013317","journal-title":"R J"},{"key":"12687_CR19","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","volume":"96","author":"ME Farrell","year":"2021","unstructured":"Farrell ME, Jiang S, Schultz AP et al (2021) Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology 96:e619\u2013e631","journal-title":"Neurology"},{"key":"12687_CR20","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","volume":"71","author":"EC Mormino","year":"2014","unstructured":"Mormino EC, Betensky RA, Hedden T et al (2014) Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol 71:1379\u20131385","journal-title":"JAMA Neurol"},{"key":"12687_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","volume":"14","author":"RF Buckley","year":"2018","unstructured":"Buckley RF, Mormino EC, Amariglio RE et al (2018) Sex, amyloid, and APOE \u03b54 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: findings from three well-characterized cohorts. Alzheimers Dement 14:1193\u20131203","journal-title":"Alzheimers Dement"},{"key":"12687_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14338","volume":"21","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Knopman DS, Arbizu J et al (2025) Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Alzheimers Dement 21:e14338","journal-title":"Alzheimers Dement"},{"key":"12687_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F et al (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis 9:197\u2013210","journal-title":"J Prev Alzheimers Dis"},{"key":"12687_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD et al (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330:512\u2013527","journal-title":"JAMA"},{"key":"12687_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388:9\u201321","journal-title":"N Engl J Med"},{"key":"12687_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100150","volume":"12","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Selkoe DJ, Schindler SE et al (2025) Donanemab: appropriate use recommendations. J Prev Alzheimers Dis 12:100150","journal-title":"J Prev Alzheimers Dis"},{"key":"12687_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76102-5","volume":"10","author":"SH Cho","year":"2020","unstructured":"Cho SH, Choe YS, Kim YJ et al (2020) Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments. Sci Rep 10:19576","journal-title":"Sci Rep"},{"key":"12687_CR28","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s00259-020-05044-x","volume":"48","author":"JY Kim","year":"2021","unstructured":"Kim JY, Oh D, Sung K et al (2021) Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden. Eur J Nucl Med Mol Imaging 48:1116\u20131123","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR29","first-page":"25","volume":"9","author":"S Salloway","year":"2017","unstructured":"Salloway S, Gamez JE, Singh U et al (2017) Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer\u2019s disease. Alzheimers Dement 9:25\u201334","journal-title":"Alzheimers Dement"},{"key":"12687_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12149-024-01977-7","volume":"39","author":"A Takenaka","year":"2025","unstructured":"Takenaka A, Nihashi T, Sakurai K et al (2025) Interrater agreement and variability in visual reading of [18F] flutemetamol PET images. Ann Nucl Med 39:68\u201376","journal-title":"Ann Nucl Med"},{"key":"12687_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70732","volume":"21","author":"DN Soleimani-Meigooni","year":"2025","unstructured":"Soleimani-Meigooni DN, Pezzoli S, Blazhenets G et al (2025) Calibration of multisite raters for prospective visual reads of amyloid PET scans. Alzheimers Dement 21:e70732","journal-title":"Alzheimers Dement"},{"key":"12687_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/MNM.0000000000000633","volume":"38","author":"CJ Buckley","year":"2017","unstructured":"Buckley CJ, Sherwin PF, Smith AP, Wolber J, Weick SM, Brooks DJ (2017) Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol \u03b2-amyloid PET brain images. Nucl Med Commun 38:234\u2013241","journal-title":"Nucl Med Commun"},{"key":"12687_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2967\/jnumed.118.211532","volume":"60","author":"LE Collij","year":"2019","unstructured":"Collij LE, Konijnenberg E, Reimand J et al (2019) Assessing amyloid pathology in cognitively normal subjects using 18F-flutemetamol PET: comparing visual reads and quantitative methods. J Nucl Med 60:541\u2013547","journal-title":"J Nucl Med"},{"key":"12687_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00259-019-04595-y","volume":"47","author":"HJ Son","year":"2020","unstructured":"Son HJ, Oh JS, Oh M et al (2020) The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases. Eur J Nucl Med Mol Imaging 47:332\u2013341","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2967\/jnumed.124.268119","volume":"66","author":"LE Collij","year":"2025","unstructured":"Collij LE, Bischof GN, Altomare D et al (2025) Quantification supports amyloid PET visual assessment of challenging cases: results from the AMYPAD diagnostic and patient management study. J Nucl Med 66:110\u2013116","journal-title":"J Nucl Med"},{"key":"12687_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s13139-019-00610-0","volume":"53","author":"JY Kim","year":"2019","unstructured":"Kim JY, Suh HY, Ryoo HG et al (2019) Amyloid PET quantification via end-to-end training of a deep learning. Nucl Med Mol Imaging 53:340\u2013348","journal-title":"Nucl Med Mol Imaging"},{"key":"12687_CR37","doi-asserted-by":"crossref","unstructured":"Bourgeat P, Dore V, Fripp J, Villemagne VL, Rowe CC, Salvado O (2015) Computational analysis of PET by AIBL (CapAIBL): a cloud-based processing pipeline for the quantification of PET images. Proc SPIE 9413:773\u2013779","DOI":"10.1117\/12.2082492"},{"key":"12687_CR38","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00259-015-2988-7","volume":"42","author":"C Hutton","year":"2015","unstructured":"Hutton C, Declerck J, Mintun MA, Pontecorvo MJ, Devous MD Sr, Joshi AD (2015) Quantification of 18F-florbetapir PET: comparison of two analysis methods. Eur J Nucl Med Mol Imaging 42:725\u2013732","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12149-016-1115-6","volume":"30","author":"WH Choi","year":"2016","unstructured":"Choi WH, Um YH, Jung WS, Kim SH (2016) Automated quantification of amyloid positron emission tomography: a comparison of PMOD and MIMneuro. Ann Nucl Med 30:682\u2013689","journal-title":"Ann Nucl Med"},{"key":"12687_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-020-00329-4","volume":"7","author":"Y Tsubaki","year":"2020","unstructured":"Tsubaki Y, Akamatsu G, Shimokawa N, Katsube S, Takashima A, Sasaki M (2020) Development and evaluation of an automated quantification tool for amyloid PET images. EJNMMI Phys 7:59","journal-title":"EJNMMI Phys"},{"key":"12687_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13195-022-01099-0","volume":"14","author":"SJ Kim","year":"2022","unstructured":"Kim SJ, Ham H, Park YH et al (2022) Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET. Alzheimers Res Ther 14:157","journal-title":"Alzheimers Res Ther"},{"key":"12687_CR42","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1007\/s00259-023-06279-0","volume":"50","author":"A Jovalekic","year":"2023","unstructured":"Jovalekic A, Ro\u00e9-Vellv\u00e9 N, Koglin N et al (2023) Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods. Eur J Nucl Med Mol Imaging 50:3276\u20133289","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12687_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36986-5","volume":"13","author":"HW Roh","year":"2023","unstructured":"Roh HW, Son SJ, Hong CH et al (2023) Comparison of automated quantification of amyloid deposition between PMOD and Heuron. Sci Rep 13:9891","journal-title":"Sci Rep"},{"key":"12687_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2023.1091506","volume":"6","author":"S Maddury","year":"2023","unstructured":"Maddury S, Desai K (2023) DeepAD: a deep learning application for predicting amyloid standardized uptake value ratio through PET for Alzheimer\u2019s prognosis. Front Artif Intell 6:1091506","journal-title":"Front Artif Intell"},{"key":"12687_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2967\/jnumed.122.264414","volume":"64","author":"SK Kang","year":"2023","unstructured":"Kang SK, Kim D, Shin SA, Kim YK, Choi H, Lee JS (2023) Fast and accurate amyloid brain PET quantification without MRI using deep neural networks. J Nucl Med 64:659\u2013666","journal-title":"J Nucl Med"},{"key":"12687_CR46","doi-asserted-by":"publisher","first-page":"7649","DOI":"10.3390\/ijms25147649","volume":"25","author":"S Kim","year":"2024","unstructured":"Kim S, Wang SM, Kang DW et al (2024) A comparative analysis of two automated quantification methods for regional cerebral amyloid retention: PET-only and PET-and-MRI-based methods. Int J Mol Sci 25:7649","journal-title":"Int J Mol Sci"},{"key":"12687_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12149-024-01919-3","volume":"38","author":"C Shang","year":"2024","unstructured":"Shang C, Sakurai K, Nihashi T et al (2024) Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods. Ann Nucl Med 38:460\u2013467","journal-title":"Ann Nucl Med"},{"key":"12687_CR48","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/diagnostics15131599","volume":"15","author":"H Yoon","year":"2025","unstructured":"Yoon H, Lee N, Um YH, Choi WH (2025) Consistency analysis of centiloid values across three commercial software platforms for amyloid PET quantification. Diagnostics (Basel) 15:1599","journal-title":"Diagnostics (Basel)"},{"key":"12687_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nicl.2017.04.025","volume":"15","author":"S Bullich","year":"2017","unstructured":"Bullich S, Seibyl J, Catafau AM et al (2017) Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. Neuroimage Clin 15:325\u2013332","journal-title":"Neuroimage Clin"},{"key":"12687_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","volume":"13","author":"SK Royse","year":"2021","unstructured":"Royse SK, Minhas DS, Lopresti BJ et al (2021) Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimers Res Ther 13:99","journal-title":"Alzheimers Res Ther"},{"key":"12687_CR51","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2967\/jnumed.114.142109","volume":"55","author":"L Thurfjell","year":"2014","unstructured":"Thurfjell L, Lilja J, Lundqvist R et al (2014) Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads. J Nucl Med 55:1623\u20131628","journal-title":"J Nucl Med"},{"key":"12687_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.578753","volume":"11","author":"H Matsuda","year":"2020","unstructured":"Matsuda H, Ito K, Ishii K et al (2020) Quantitative evaluation of 18F-flutemetamol PET in patients with cognitive impairment and suspected Alzheimer\u2019s disease: a multicenter study. Front Neurol 11:578753","journal-title":"Front Neurol"},{"key":"12687_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-024-01193-4","volume":"15","author":"YJ Park","year":"2025","unstructured":"Park YJ, Moon SY, Yoon JK, Lee SJ, An YS (2025) Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET. EJNMMI Res 15:1","journal-title":"EJNMMI Res"},{"key":"12687_CR54","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","volume":"52","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Ong K, Mulligan RS et al (2011) Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias. J Nucl Med 52:1210\u20131217","journal-title":"J Nucl Med"},{"key":"12687_CR55","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J et al (2015) Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement 11:964\u2013974","journal-title":"Alzheimers Dement"},{"key":"12687_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3988\/jcn.2022.0207","volume":"19","author":"K Baik","year":"2023","unstructured":"Baik K, Jeon S, Park M et al (2023) Comparison between 18F-florapronol and 18F-florbetaben imaging in patients with cognitive impairment. J Clin Neurol 19:260\u2013269","journal-title":"J Clin Neurol"},{"key":"12687_CR57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12149-023-01824-1","volume":"37","author":"YJ Jeong","year":"2023","unstructured":"Jeong YJ, Yoon HJ, Kang DY, Park KW (2023) Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals. Ann Nucl Med 37:271\u2013279","journal-title":"Ann Nucl Med"},{"key":"12687_CR58","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jamaneurol.2025.2218","volume":"82","author":"E Zeltzer","year":"2025","unstructured":"Zeltzer E, Schonhaut DR, Mundada NS et al (2025) Concordance between amyloid-PET quantification and real-world visual reads. JAMA Neurol 82:952\u2013962","journal-title":"JAMA Neurol"},{"key":"12687_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13139-024-00845-6","volume":"58","author":"K Xu","year":"2024","unstructured":"Xu K, Kang H (2024) A review of machine learning approaches for brain positron emission tomography data analysis. Nucl Med Mol Imaging 58:203\u2013212","journal-title":"Nucl Med Mol Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12687-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:02:05Z","timestamp":1791936125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12687-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["12687"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12687-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The scientific guarantor of this publication is Sang-woo Lee.","order":1,"name":"Ethics","label":"Guarantor","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C.M.H. received research grants from Futurechem (South Korea) and Neurophet (South Korea) and received consultation fees from IPSEN Korea, Neurophet, and GE Healthcare. Y.S.C. and D.K. are affiliated with Neurophet Inc. For the remaining authors, there are no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No complex statistical methods were necessary for this paper.","order":3,"name":"Ethics","label":"Statistics and biometry","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Daegu Joint Institutional Review Board (2022-12-300) and Institutional Review Board of St. Mary Hospital (KC23DNDS0501) approved this study.","order":5,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Study subjects or cohorts overlap","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"order":7,"name":"Ethics","label":"Methodology","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}